Trial · NCT00232180
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind (DB) Phase | STARTED | Eplerenone: Double-blind Phase | 1,367 | |
| Double-blind (DB) Phase | STARTED | Placebo: Double-blind Phase | 1,376 | |
| Double-blind (DB) Phase | STARTED | Eplerenone: Open Label Phase | 0 | |
| Double-blind (DB) Phase | Treated | Eplerenone: Double-blind Phase | 1,364 | |
| Double-blind (DB) Phase | Treated | Placebo: Double-blind Phase | 1,372 | |
| Double-blind (DB) Phase | Treated | Eplerenone: Open Label Phase | 0 | |
| Double-blind (DB) Phase | COMPLETED | Eplerenone: Double-blind Phase | 826 | |
| Double-blind (DB) Phase | COMPLETED | Placebo: Double-blind Phase | 771 | |
| Double-blind (DB) Phase | COMPLETED | Eplerenone: Open Label Phase | 0 | |
| Double-blind (DB) Phase | NOT COMPLETED | Eplerenone: Double-blind Phase | 541 | |
| Double-blind (DB) Phase | NOT COMPLETED | Placebo: Double-blind Phase | 605 | |
| Double-blind (DB) Phase | NOT COMPLETED | Eplerenone: Open Label Phase | 0 | |
| Open Label Phase | STARTED | Eplerenone: Double-blind Phase | 0 | |
| Open Label Phase | STARTED | Placebo: Double-blind Phase | 0 | |
| Open Label Phase | STARTED | Eplerenone: Open Label Phase | 1,246 | |
| Open Label Phase | Treated | Eplerenone: Double-blind Phase | 0 | |
| Open Label Phase | Treated | Placebo: Double-blind Phase | 0 | |
| Open Label Phase | Treated | Eplerenone: Open Label Phase | 1,245 | |
| Open Label Phase | COMPLETED | Eplerenone: Double-blind Phase | 0 | |
| Open Label Phase | COMPLETED | Placebo: Double-blind Phase | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00232180/flow